Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gossamer Bio Usa, Inc.

Clinical trials sponsored by Gossamer Bio Usa, Inc., explained in plain language.

Now part of Gossamer Bio, Inc. GOSS NASDAQ

A clinical-stage biopharmaceutical company developing therapies for pulmonary and inflammatory diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1

New inhaled drug shows promise for rare lung disease

Disease control Ongoing

This study looks at the long-term safety of an inhaled drug called GB002 for people with pulmonary arterial hypertension (PAH), a serious lung condition. It includes 74 patients who already completed a previous GB002 study. Researchers will track side effects and measure how far …

Phase: PHASE2 • Sponsor: Gossamer Bio USA, Inc. • Aim: Disease control

Last updated Jul 29, 2026 00:00 UTC